1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797632420986486784 |
---|---|
author | Scott Garforth Harris Goldstein Steven Almo Christopher R Hiner |
author_facet | Scott Garforth Harris Goldstein Steven Almo Christopher R Hiner |
author_sort | Scott Garforth |
collection | DOAJ |
first_indexed | 2024-03-11T11:37:46Z |
format | Article |
id | doaj.art-8efb06b8ead147f1a7d91340f55c5509 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T11:37:46Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-8efb06b8ead147f1a7d91340f55c55092023-11-10T12:45:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11701170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cellsScott Garforth0Harris Goldstein1Steven Almo2Christopher R Hiner31Albert Einstein College of Medicine, Bronx, NY, USA1Albert Einstein College of Medicine, Bronx, NY, USAAlbert Einstein College of Medicine, Bronx, NY, USAAlbert Einstein College of Medicine, Bronx, NY, USA |
spellingShingle | Scott Garforth Harris Goldstein Steven Almo Christopher R Hiner 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells Journal for ImmunoTherapy of Cancer |
title | 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells |
title_full | 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells |
title_fullStr | 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells |
title_full_unstemmed | 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells |
title_short | 1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells |
title_sort | 1170 development of a fusion protein bispecific for a cmv specific tcr and cd19 which selectively activates and expands cmv specific ctls and redirects them to eliminate b cell leukemia cells |
work_keys_str_mv | AT scottgarforth 1170developmentofafusionproteinbispecificforacmvspecifictcrandcd19whichselectivelyactivatesandexpandscmvspecificctlsandredirectsthemtoeliminatebcellleukemiacells AT harrisgoldstein 1170developmentofafusionproteinbispecificforacmvspecifictcrandcd19whichselectivelyactivatesandexpandscmvspecificctlsandredirectsthemtoeliminatebcellleukemiacells AT stevenalmo 1170developmentofafusionproteinbispecificforacmvspecifictcrandcd19whichselectivelyactivatesandexpandscmvspecificctlsandredirectsthemtoeliminatebcellleukemiacells AT christopherrhiner 1170developmentofafusionproteinbispecificforacmvspecifictcrandcd19whichselectivelyactivatesandexpandscmvspecificctlsandredirectsthemtoeliminatebcellleukemiacells |